Veeva Commercial Summit – ACTO, a long-time Veeva Technology Partner and early member of the Veeva AI Partner Program, announced the upcoming release of the next-generation LAICA™ (Life Sciences AI Conversational Assistant) , the industry’s first AI-powered knowledge assistant specifically designed for pharmaceutical field teams.
The next generation of LAICA will deliver greater levels of personalization and intelligence to help field staff prepare more efficiently and engage HCPs with greater confidence and relevance.
“When we launched LAICA three years ago, it marked the beginning of a transformation in how field teams access and work with critical knowledge,” says Parth Khanna , Managing Director of ACTO . “AI doesn’t stand still. It evolves, constantly learning, adapting, and drawing conclusions to deliver more accurate, relevant, and personalized answers. The real magic happens when an AI assistant like LAICA meets people where they are and understands their needs, constraints, motivations, and intent. For LAICA, the experience, combined with the incredible advances in AI technology, has resulted in a truly intelligent, role-aware assistant that delivers personalized, contextual answers and suggestions that field teams can rely on in real time.”
Also Read: Viralgen collaborates with Trogenix to advance AAV gene therapy for glioblastoma
This broader “universe of knowledge” will significantly enhance LAICA’s cognitive intelligence – its ability to process complex inputs and generate precise, compliant responses.
“The ultimate goal is to help our field sales teams have impactful, personalized conversations with healthcare professionals,” says Lisa Dreher , director of national sales training at Currax Pharmaceuticals . “LAICA will help enable this by giving field sales representatives quick, role-specific access to the knowledge they need, along with relevant suggestions. This improves pre-call planning and enhances the quality of every interaction with healthcare professionals.”
SOURCE: PRNewswire